European pharma companies warn Trump's tariffs could expedite shift to US

Top European pharmaceutical companies have warned European Commission President Ursula von der Leyen that looming U.S. tariffs could accelerate an industry-wide shift from Europe to the United States unless swift regulatory reforms are enacted.

European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite the industry's shift away from Europe and toward the United States.

Pharma trade lobby EFPIA, whose members include European pharma giants Bayer BAYGn.DE, Novartis NOVN.S and Novo Nordisk NOVOb.CO, said it had called on EU President Ursula von der Leyen to push for "rapid and radical action" to mitigate the "risk of exodus" to the United States.

Pharmaceuticals were exempt from sweeping tariffs on U.S. imports announced by U.S. President Donald Trump last week but he has said they will face separate tariffs.

EFPIA said the EU needs to change its regulatory framework for the industry to make it more conducive to innovation and strengthen Europe's intellectual property provisions.

The demands were not new. EFPIA has repeatedly warned that Europe's pharma sector will lose out to increased competition from the U.S., China and emerging markets if the EU does not amend a proposed revamp of laws governing the sector.

"Now with the addition of tariffs, there is little incentive to invest in the EU and significant drivers to relocate to the U.S.," the EFPIA statement read.

The Commission did not immediately reply to a request for comment.

The CEOs of EU-headquartered pharma companies as well as biotech lobby Europabio and generics trade group Medicines for Europe were invited to the meeting, but Europe's largest generics maker, Sandoz SDZ.S, told Reuters it was not.

Europe and the U.S. have interconnected supply chains for medicines. The U.S. depends on medicines partly produced in Europe that bring in hundreds of billions of dollars in revenue.

EU medical and pharmaceutical product exports to the United States totalled about 90 billion euros ($97.05 billion) in 2023, according to latest Eurostat data.

European pharma giants have recently been expanding production facilities in the United States.

The United States is the biggest pharma market by sales for big pharma companies, both U.S. and European headquartered ones. Sales in North America accounted for nearly 50% of world pharmaceutical sales in 2021, compared with nearly 25% for Europe, according to EFPIA.

The European Commission on Monday proposed counter-tariffs of 25% on a range of U.S. goods, including soybeans, nuts and motorcycles.

Read next

21:30

World News

Bangladesh orders striking tax officials back to work; port operations hindered

The government of Bangladesh has ordered tax and customs officials to immediately end a two-day nationwide strike that has paralysed tax operations, including customs services at the country’s key trade gateway, Chittagong Port.

20:57

Russia

Lavrov says Macron, Merz have lost common sense

Russian Foreign Minister Sergey Lavrov has accused French President Macron and German Chancellor Merz of losing common sense over their stance on Russia, also calling Kyiv a "Nazi regime".

14:03

Tuvalu

Thousands of Tuvalu residents seek Australian climate visas as seas rise

Over a third of Tuvalu's population has applied for Australia's climate visa, as rising sea levels threaten to submerge the Pacific nation within decades.

12:00

Italy

Data failure at Milan control centre disrupts over 300 flights

A data transmission failure at Milan's Area Control Center has suspended over 300 flights across northwest Italy since Saturday evening.

11:00

Pakistan

Pakistan operation kills 14 militants following deadly convoy blast

Fourteen militants were killed in a security operation following a deadly suicide bombing on a military convoy in northwest Pakistan that left 13 soldiers dead.